Brief: Jhbp Cy Posts Loss For Year RMB865.4 Mln
30/03/2022 16:12
March 30 (Reuters) - Genor Biopharma:
* LOSS FOR YEAR RMB865.4 MILLION VERSUS LOSS OF RMB3.03
BILLION
Source text for Eikon: ID:nHKS7mZ2d4
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman